2025-03-12 17:28:54
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Vivanza Biosciences Ltd Q2FY22 consolidated profit at Rs. 25.88 lakhs
Posted On : 2021-10-29 15:59:51( TIMEZONE : IST )
Vivanza Biosciences Ltd has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 3.1242 crores during the period ended September 30, 2021 as compared to Rs. 0.7096 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 0.2588 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 0.3218 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 0.65 for the period ended September 30, 2021 as compared to Rs. 0.80 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 3.1242 crs | ₹0.7096 crs |  340.28% |
| Net Profit | ₹0.2588 crs | ₹0.3218 crs |  -19.58% |
| EPS | ₹0.65 | ₹0.80 | -18.75% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 3.1242 crores during the period ended September 30, 2021 as compared to Rs.2.5741 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.0.2588 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.0.2065 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.0.65 for the period ended September 30, 2021 as compared to Rs.0.52 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 3.1242 crs | ₹2.5741 crs | 21.37% |
| Net Profit | ₹0.2588 crs | ₹0.2065 crs | 25.33% |
| EPS | ₹0.65 | ₹0.52 | 25.00% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.3.8338 crores during the 6 Months period ended September 30, 2021 as compared to Rs.3.2642 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.0.5806 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.0.0383 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.1.45 for the 6 Months period ended September 30, 2021 as compared to Rs.0.10 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹3.8338 crs | ₹3.2642 crs | 17.45% |
| Net Profit | ₹0.5806 crs | ₹0.0383 crs | 1,415.93% |
| EPS | ₹1.45 | ₹0.10 | 1,350.00% |
Shares of Vivanza Biosciences Ltd was last trading in BSE at Rs. 192.00 as compared to the previous close of Rs. 183.35. The total number of shares traded during the day was 1 in over 1 trades.
The stock hit an intraday high of Rs. 192.00 and intraday low of 192.00. The net turnover during the day was Rs. 192.00.
